We are live on ! Find out more
CCC

Chelsea Counsel Company Portfolio holdings

AUM $236M
1-Year Est. Return 51.76%
This Fund
S&P 500
This Quarter Est. Return
+5.92%
1 Year Est. Return
+51.76%
3 Year Est. Return
+106.38%
5 Year Est. Return
+132.3%
10 Year Est. Return
+407.64%
AUM
$203M
AUM Growth
+$2.55M
Cap. Flow
-$6.69M
Cap. Flow %
-3.3%
Top 10 Hldgs %
46.82%
Holding
204
New
5
Increased
21
Reduced
43
Closed
5

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$899K
2
ASML icon
ASML
ASML
+$447K
3
GS icon
Goldman Sachs
GS
+$147K
4
NFLX icon
Netflix
NFLX
+$134K
5
MO icon
Altria Group
MO
+$74K

Top Sells

Rank Stock Value
1
COST icon
Costco
COST
+$753K
2
DVN icon
Devon Energy
DVN
+$731K
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$701K
4
XOM icon
ExxonMobil
XOM
+$662K
5
TMO icon
Thermo Fisher Scientific
TMO
+$580K

Sector Composition

Rank Sector Weight
1 Technology 19.96%
2 Industrials 13.84%
3 Energy 12.85%
4 Healthcare 11.53%
5 Communication Services 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BAC icon
51
Bank of America
BAC
$448B
$821K 0.4%
20,700
– –
GD icon
52
General Dynamics
GD
$106B
$781K 0.39%
2,585
– –
NOC icon
53
Northrop Grumman
NOC
$81.8B
$764K 0.38%
1,446
– –
DVN icon
54
Devon Energy
DVN
$49.9B
$759K 0.37%
19,400
-16,605
-46% -$731K
PFE icon
55
Pfizer
PFE
$152B
$749K 0.37%
25,870
-300
-1% -$8.75K
POR icon
56
Portland General Electric
POR
$5.69B
$741K 0.36%
15,300
– –
TECK icon
57
Teck Resources
TECK
$32.4B
$730K 0.36%
13,975
– –
ABNB icon
58
Airbnb
ABNB
$111B
$725K 0.36%
5,716
-220
-4% -$28.5K
IBB icon
59
iShares Biotechnology ETF
IBB
$9.81B
$711K 0.35%
4,880
-730
-13% -$106K
MPLX icon
60
MPLX
MPLX
$60.1B
$667K 0.33%
15,000
– –
EOG icon
61
EOG Resources
EOG
$75.2B
$641K 0.32%
5,215
+100
+2% +$12.6K
DIA icon
62
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.2B
$637K 0.31%
1,500
– –
LMT icon
63
Lockheed Martin
LMT
$138B
$618K 0.3%
1,057
– –
CCJ icon
64
Cameco
CCJ
$43B
$573K 0.28%
12,000
– –
CL icon
65
Colgate-Palmolive
CL
$73.6B
$571K 0.28%
5,500
+500
+10% +$51K
FCX icon
66
Freeport-McMoran
FCX
$96.4B
$552K 0.27%
11,050
– –
KVUE icon
67
Kenvue
KVUE
$36.6B
$522K 0.26%
22,558
-3,252
-13% -$67.4K
MRNA icon
68
Moderna
MRNA
$24.2B
$495K 0.24%
7,404
-635
-8% -$58.3K
MAIN icon
69
Main Street Capital
MAIN
$5.52B
$490K 0.24%
9,780
– –
IBM icon
70
IBM
IBM
$225B
$454K 0.22%
2,055
– –
PNW icon
71
Pinnacle West Capital
PNW
$12.1B
$438K 0.22%
4,939
– –
BRK.B icon
72
Berkshire Hathaway Class B
BRK.B
$1.11T
$432K 0.21%
939
– –
CTVA icon
73
Corteva
CTVA
$50.9B
$420K 0.21%
7,150
– –
ASML icon
74
ASML
ASML
$691B
$417K 0.21%
+500
New +$447K
NEE icon
75
NextEra Energy
NEE
$179B
$416K 0.21%
4,920
– –
1 2
3
4 5

Similar funds

TCM
Tekne Capital Management New York $237M AUM 62.98% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
JRPCML
J. R. Prunier Capital Management LLC Holden, Massachusetts $235M AUM
BCM
Birmingham Capital Management Birmingham, Alabama $237M AUM 32.7% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
CF
CNA Financial Chicago, Illinois $235M AUM 3.39% 1-Year Est. Return
MC
Matisse Capital Portland, Oregon $234M AUM 19.72% 1-Year Est. Return
BWM
Bernard Wealth Management Royal Oak, Michigan $234M AUM 27.82% 1-Year Est. Return

Chelsea Counsel Company's Q3 2024 Portfolio in Review

As of Q3 2024, Chelsea Counsel Company held 204 positions worth $203M, up 1.3% from $200M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Chelsea Counsel Company withdrew a net $6.69M in Q3 2024, closing 5 positions and reducing 43 holdings. Its most notable exit was UnitedHealth, an estimated $25.5K position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Industrials and Energy.

Against the trend, Chelsea Counsel Company opened a new position in ASML worth $417K.

  • Chelsea Counsel Company's largest Q3 2024 buy was ASML: 500 shares worth $417K.
  • Chelsea Counsel Company added most to Eli Lilly in Q3 2024, an estimated $899K increase.
  • Chelsea Counsel Company's biggest Q3 2024 reduction was Costco, cutting an estimated $753K.
  • Chelsea Counsel Company fully exited UnitedHealth in Q3 2024, selling an estimated $25.5K.
  • Chelsea Counsel Company's ten largest holdings make up 47% of its $203M portfolio in Q3 2024.
  • Chelsea Counsel Company opened 5 new positions and closed 5 in Q3 2024.
  • Chelsea Counsel Company's portfolio value rose 1.3% quarter-over-quarter to $203M.

Based on Chelsea Counsel Company's 13F filing for Q3 2024, filed 21 Nov 2024.